Post Thumbnail

We are proudly sponsoring the 2023 OARSI Conference in Denver to advance osteoarthritis treatment and prevention

At TRB Chemedica, we are committed to advancing the field of osteoarthritis treatment by researching, developing, manufacturing, and marketing various molecules, such as hyaluronic acid and diacerein, to manage osteoarthritis-induced pain.

As osteoarthritis is one of our areas of focus, we are pleased to announce our sponsorship of this year’s Osteoarthritis Research Society International (OARSI) conference in Denver, which is dedicated to advancing prevention and treatment of osteoarthritis, and thus support their mission.

Learn more

You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.

As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.

CONTINUE